zidovudine has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carroll, SL; Jacobson, IV; Milross, CG; Post, JJ; Varma, R | 1 |
1 other study(ies) available for zidovudine and Lymphoma, B-Cell, Marginal Zone
Article | Year |
---|---|
Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Humans; Lamivudine; Lopinavir; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Nasopharyngeal Neoplasms; Pyrimidinones; Radiotherapy, Adjuvant; Remission Induction; Ritonavir; Viral Load; Zidovudine | 2011 |